Search for Clinical Trial Results

Sponsored By

Hemorrhagic Fever - 27 Studies Found

Status Study
Enrolling by invitation Study Name: Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Condition: Viral Hemorrhagic Fever
Date: 2015-06-24
Interventions: Drug: Ribavirin
  • Loading do
    		•
    Active, not recruiting Study Name: Phase I Study to Evaluate Basic Pharmacodynamic, Pharmacological and Toxicological Effects of the Newly Developed Crimean-Congo Hemorrhagic Fever Vaccine for Humans
    Condition: Crimean-Congo Hemorrhagic Fever
    Date: 2017-01-11
    Interventions:
    • Biological: KIRIM-KONGO-VAX Cr
    Enrolling by invitation Study Name: Treatment of Viral Hemorrhagic Fevers With Intravenous Ribavirin in Military Treatment Facilities
    Condition:
    • Crimean-Congo Hemorrhagic Fever
    • Lassa Fever

    Date: 2009-10-08
    Interventions: Drug: Ribavirin (Virazole) Injection The drug is to be adm
    Active, not recruiting Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
    Condition: Hemorrhagic Fever, Ebola
    Date: 2015-01-29
    Interventions:
    • Biological: cAd3-EBOZ cAd3 vac
    Recruiting Study Name: Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi
    Condition: Ebola Hemorrhagic Fever
    Date: 2016-09-14
    Interventions: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
    Recruiting Study Name: Open Study of the Duration of Immunity After Vaccination With GamEvac
    Condition: Hemorrhagic Fever, Ebola
    Date: 2016-09-14
    Interventions: Procedure: blood sampling collection It is an observational study; no interventions are planned in the c
    Recruiting Study Name: Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo
    Condition: Hemorrhagic Fever, Ebola
    Date: 2015-11-04
    Interventions:
    • Biological: Ad26.ZEBOV One 0.5
    Recruiting Study Name: Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
    Condition: Hemorrhagic Fever, Ebola
    Date: 2016-01-08
    Interventions:
    • Biological: Ad26.ZEBOV No vacc
    Withdrawn Study Name: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
    Condition: Ebola Hemorrhagic Fever
    Date: 2012-05-03
    Interventions:
    • Drug: AVI-7537

    Completed Study Name: Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
    Condition: Ebola Hemorrhagic Fever
    Date: 2011-05-10
    Interventions:
    • Drug: Placebo Normal saline
    Next >>>